The Functional Role of microRNAs and mRNAs in Diabetic Kidney Disease: A Review
Bhuvnesh Rai1, Jyotika Srivastava1, Pragati Saxena1
1Stem Cell Research Center, Department of Hematology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Abstract:
Diabetes is a group of diseases marked by poor control of blood glucose levels. Diabetes mellitus (DM) occurs when pancreatic cells fail to make insulin, which is required to keep blood glucose levels stable, disorders, and so on. High glucose levels in the blood induce diabetic effects, which can cause catastrophic damage to bodily organs such as the eyes and lower extremities. Diabetes is classified into many forms, one of which is controlled by hyperglycemia or Diabetic Kidney Disease (DKD), and another that is not controlled by hyperglycemia (nondiabetic kidney disease or NDKD) and is caused by other factors such as hypertension, hereditary. DKD is associated with diabetic nephropathy (DN), a leading cause of chronic kidney disease (CKD) and end-stage renal failure. The disease is characterized by glomerular basement membrane thickening, glomerular sclerosis, and mesangial expansion, resulting in a progressive decrease in glomerular filtration rate, glomerular hypertension, and renal failure or nephrotic syndrome. It is also represented by some microvascular complications such as nerve ischemia produced by intracellular metabolic changes, microvascular illness, and the direct impact of excessive blood glucose on neuronal activity. Therefore, DKD-induced nephrotic failure is worse than NDKD. MicroRNAs (miRNAs) are important in the development and progression of several diseases, including diabetic kidney disease (DKD). These dysregulated miRNAs can impact various cellular processes, including inflammation, fibrosis, oxidative stress, and apoptosis, all of which are implicated during DKD. MiRNAs can alter the course of DKD by targeting several essential mechanisms. Understanding the miRNAs implicated in DKD and their involvement in disease development might lead to identifying possible therapeutic targets for DKD prevention and therapy. Therefore, this review focuses specifically on DKD-associated DN, as well as how in-silico approaches may aid in improving the management of the disease.
Insights
Diabetic Kidney Disease (DKD) involves microRNAs (miRNAs) impacting inflammation and fibrosis. Understanding these miRNAs may offer new therapeutic targets for DKD prevention and treatment.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Diabetes Mellitus (DM) is characterized by poor blood glucose control, leading to organ damage.
- Diabetic Kidney Disease (DKD) is a major cause of chronic kidney disease and renal failure.
- DKD involves specific pathological changes like glomerular basement membrane thickening and sclerosis.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in the development and progression of Diabetic Kidney Disease (DKD).
- To explore how dysregulated miRNAs influence cellular processes implicated in DKD.
- To highlight the potential of in-silico approaches for managing DKD.
Main Methods:
- Literature review focusing on DKD-associated diabetic nephropathy (DN).
- Analysis of the impact of microRNAs (miRNAs) on cellular mechanisms in DKD.
- Discussion of in-silico strategies for DKD management.
Main Results:
- Dysregulated miRNAs significantly contribute to inflammation, fibrosis, oxidative stress, and apoptosis in DKD.
- MiRNAs target essential pathways, altering the course of DKD progression.
- DKD-induced nephrotic failure is considered more severe than non-diabetic kidney disease (NDKD).
Conclusions:
- MicroRNAs (miRNAs) play a critical role in DKD pathogenesis.
- Targeting miRNAs presents a promising therapeutic avenue for DKD.
- In-silico methods show potential for improving DKD management strategies.
Related Concept Videos
MicroRNAs
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


